How Novavax Could Shake Up the COVID Vaccine Market

·4-min read

Moderna (NASDAQ: MRNA), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE) and its partner BioNTech (NASDAQ: BNTX) share the U.S. COVID-19 vaccine market right now. In this Motley Fool Live video recorded on July 21, healthcare and cannabis bureau editor-analyst Olivia Zitkus and Motley Fool contributor Keith Speights discuss how Novavax (NASDAQ: NVAX) could potentially shake up the COVID vaccine market.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting